Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japanese approval for St Jude's Durata defibrillation lead

This article was originally published in Clinica

Executive Summary

St Jude Medical's Durata defibrillation lead has received regulatory approval from the Japanese Ministry of Health, Labour and Welfare (MHLW). Reimbursement approval for the high-voltage lead, used to implant an implantable cardioverter defibrillator in patients at risk of ventricular tachycardia, was also granted. The Durata lead is, at 7 French, the smallest diameter high-voltage lead on the market. It has a soft silicone tip with a larger surface area and a slightly curved right ventricle shock coil intended to enhance ease of use. It also incorporates Optim, a hybrid insulation material developed by St Paul, Minnesota-based St Jude specifically for cardiac leads.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT041547

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel